Latest On-Demand Webinars & Online Events

In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.

This exclusive Q&A event invites you to ask anything about the world of predatory conferences to our expert speaker.

In this webinar, our expert speaker will discuss how these complementary techniques can be performed on the ZenoTOF instrument to localize modifications on therapeutic mAbs.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.

Water is essential for life and for the successful operation of most of today’s commercial buildings. For most of us though our greatest regular interaction with it is to just turn on a tap. If water is not managed properly, however, it can have a significant and profound effect on the health of the people occupying those buildings too.

Watch this webinar to learn more about applications for screening and characterizing antibody and antibody fragments plus a label-free technology which uses surface plasmon resonance (a biophysical technology) for characterizing antibodies.

Amplicon-based sequencing approaches have been widely adopted for routine microbiology applications, including targeted 16S rRNA for bacterial taxonomic classification and tiled multiplex PCR for viral whole-genome sequencing.

The nitrocellulose membrane (NC) is the heart of a lateral flow assay. It is where the target and control molecules are captured and where the test results are read.
Join our webinar, hosted by Klaus Hochleitner, to take a deep dive into nitrocellulose membranes including the raw material, structure manufacturing process and capillary flow time and how these affect your lateral flow assays.
Klaus will also cover the effect of surfactants on protein binding and membrane properties and how to deal with unspecific binding of proteins to nitrocellulose membranes.

Antibodies are ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have enabled drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies.

Join our webinar, hosted by Klaus Hochleitner, to discuss key considerations for lateral flow test development and optimization and troubleshooting techniques for different samples, tests and antibodies.